AAIC 2025 Abstract
A dual 6‐month (stage 1) & 18‐month (stage 2) prospective, randomized, placebo‐controlled, double‐blind, pivotal clinical trial investigating efficacy and safety of buntanetap in early Alzheimer's patients
Trial in peopleInterventions
Abstract
Background: Annovis Bio initiated a new pivotal clinical trial in early Alzheimer's disease (AD).
